A detailed history of Van Hulzen Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 30,390 shares of ABT stock, worth $3.58 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
30,390
Previous 28,731 5.77%
Holding current value
$3.58 Million
Previous $2.99 Million 16.08%
% of portfolio
0.25%
Previous 0.2%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $166,016 - $195,977
1,659 Added 5.77%
30,390 $3.47 Million
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $46,235 - $51,609
459 Added 1.62%
28,731 $2.99 Million
Q1 2024

May 06, 2024

SELL
$109.52 - $120.96 $85,206 - $94,106
-778 Reduced 2.68%
28,272 $3.21 Million
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $111,384 - $136,344
1,235 Added 4.44%
29,050 $3.2 Million
Q3 2023

Nov 07, 2023

BUY
$95.53 - $114.62 $2.1 Million - $2.52 Million
22,009 Added 379.07%
27,815 $2.69 Million
Q2 2023

Aug 03, 2023

BUY
$100.78 - $112.29 $246,507 - $274,661
2,446 Added 72.8%
5,806 $633,000
Q1 2023

Apr 28, 2023

SELL
$96.86 - $114.01 $8,620 - $10,146
-89 Reduced 2.58%
3,360 $340,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $2,756 - $3,234
29 Added 0.85%
3,449 $379,000
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $2,419 - $2,800
-25 Reduced 0.73%
3,420 $331,000
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $18,270 - $22,083
-179 Reduced 4.94%
3,445 $374,000
Q1 2022

May 20, 2022

BUY
$114.02 - $139.04 $71,262 - $86,900
625 Added 20.84%
3,624 $429,000
Q4 2021

Feb 04, 2022

SELL
$115.53 - $141.46 $4,274 - $5,234
-37 Reduced 1.22%
2,999 $422,000
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $31,031 - $34,329
266 Added 9.6%
3,036 $359,000
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $142,816 - $168,115
-1,350 Reduced 32.77%
2,770 $321,000
Q3 2020

Nov 03, 2020

SELL
$91.64 - $111.29 $67,905 - $82,465
-741 Reduced 15.24%
4,120 $448,000
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $842 - $1,078
-11 Reduced 0.23%
4,861 $444,000
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $49,627 - $72,569
-790 Reduced 13.95%
4,872 $384,000
Q4 2019

Feb 12, 2020

SELL
$78.51 - $87.4 $8,243 - $9,177
-105 Reduced 1.82%
5,662 $492,000
Q3 2019

Oct 30, 2019

BUY
$81.84 - $88.74 $1,964 - $2,129
24 Added 0.42%
5,767 $483,000
Q2 2019

Aug 08, 2019

BUY
$72.88 - $85.0 $80,240 - $93,585
1,101 Added 23.72%
5,743 $483,000
Q1 2019

May 01, 2019

SELL
$66.22 - $80.06 $57,743 - $69,812
-872 Reduced 15.81%
4,642 $371,000
Q4 2018

Feb 12, 2019

BUY
$65.56 - $74.27 $3,671 - $4,159
56 Added 1.03%
5,514 $399,000
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $24,324 - $29,344
400 Added 7.91%
5,458 $400,000
Q2 2018

Aug 07, 2018

BUY
$57.57 - $63.54 $17,328 - $19,125
301 Added 6.33%
5,058 $308,000
Q1 2018

May 08, 2018

BUY
$56.27 - $63.62 $3,151 - $3,562
56 Added 1.19%
4,757 $285,000
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $26,356 - $28,217
491 Added 11.66%
4,701 $268,000
Q3 2017

Nov 09, 2017

SELL
$48.06 - $53.64 $132,116 - $147,456
-2,749 Reduced 39.5%
4,210 $225,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,959
6,959 $338,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Van Hulzen Asset Management, LLC Portfolio

Follow Van Hulzen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.